001     130952
005     20240228145559.0
024 7 _ |a 10.15252/embr.201744137
|2 doi
024 7 _ |a pmid:28893863
|2 pmid
024 7 _ |a pmc:PMC5666605
|2 pmc
024 7 _ |a 1469-221X
|2 ISSN
024 7 _ |a 1469-3178
|2 ISSN
024 7 _ |a altmetric:25262417
|2 altmetric
037 _ _ |a DKFZ-2017-06028
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Dräger, Nina
|0 P:(DE-He78)44dc011368b331679dbc8d341ae41420
|b 0
|e First author
|u dkfz
245 _ _ |a Bin1 directly remodels actin dynamics through its BAR domain.
260 _ _ |a Heidelberg
|c 2017
|b EMBO Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1526450005_19740
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a DKFZ-ZMBH-Allianz
520 _ _ |a Endocytic processes are facilitated by both curvature-generating BAR-domain proteins and the coordinated polymerization of actin filaments. Under physiological conditions, the N-BAR protein Bin1 has been shown to sense and curve membranes in a variety of cellular processes. Recent studies have identified Bin1 as a risk factor for Alzheimers disease, although its possible pathological function in neurodegeneration is currently unknown. Here, we report that Bin1 not only shapes membranes, but is also directly involved in actin binding through its BAR domain. We observed a moderate actin bundling activity by human Bin1 and describe its ability to stabilize actin filaments against depolymerization. Moreover, Bin1 is also involved in stabilizing tau-induced actin bundles, which are neuropathological hallmarks of Alzheimers disease. We also provide evidence for this effect in vivo, where we observed that downregulation of Bin1 in a Drosophila model of tauopathy significantly reduces the appearance of tau-induced actin inclusions. Together, these findings reveal the ability of Bin1 to modify actin dynamics and provide a possible mechanistic connection between Bin1 and tau-induced pathobiological changes of the actin cytoskeleton.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Nachman, Eliana
|0 P:(DE-He78)8fb1154d3b554bce1ecf653af8b5ea30
|b 1
|u dkfz
700 1 _ |a Winterhoff, Moritz
|b 2
700 1 _ |a Brühmann, Stefan
|b 3
700 1 _ |a Shah, Pranav
|0 P:(DE-He78)7d71bf7e3b8407442727c915a8180b86
|b 4
|u dkfz
700 1 _ |a Katsinelos, Taxiarchis
|0 P:(DE-He78)f10e8e85107a44f96026964428163c18
|b 5
|u dkfz
700 1 _ |a Boulant, Steeve
|0 P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f
|b 6
|u dkfz
700 1 _ |a Teleman, Aurelio A
|0 0000-0002-4237-9368
|b 7
700 1 _ |a Faix, Jan
|0 0000-0003-1803-9192
|b 8
700 1 _ |a Jahn, Thomas R
|0 0000-0002-9266-6736
|b 9
|e Last author
773 _ _ |a 10.15252/embr.201744137
|g Vol. 18, no. 11, p. 2051 - 2066
|0 PERI:(DE-600)2025376-X
|n 11
|p 2051 - 2066
|t EMBO reports
|v 18
|y 2017
|x 1469-3178
909 C O |o oai:inrepo02.dkfz.de:130952
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)44dc011368b331679dbc8d341ae41420
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)8fb1154d3b554bce1ecf653af8b5ea30
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)7d71bf7e3b8407442727c915a8180b86
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)f10e8e85107a44f96026964428163c18
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 0000-0002-4237-9368
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 0000-0002-9266-6736
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EMBO REP : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EMBO REP : 2015
920 1 _ |0 I:(DE-He78)B180-20160331
|k B180
|l Proteostase neurodegenerativer Erkrankungen
|x 0
920 1 _ |0 I:(DE-He78)F140-20160331
|k F140
|l Zelluläre Polarität und virale Infektion
|x 1
920 1 _ |0 I:(DE-He78)B140-20160331
|k B140
|l Signal Transduction in Cancer and Metabolism
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B180-20160331
980 _ _ |a I:(DE-He78)F140-20160331
980 _ _ |a I:(DE-He78)B140-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21